1. Home
  2. /
  3. Availability
  4. /
  5. New Tuberculosis vaccines for people with HIV

New Tuberculosis vaccines for people with HIV

Description

Mathematical modelling study assessing how different strategies for vaccinating people with and without HIV could reduce TB cases among people with HIV in high HIV/TB burden countries
TB vaccine theme
Availability
Epidemiological impact

Project details

Country
Angola, Botswana, Cameroon, Eswatini, Kenya, Losotho, Malawi, Namibia, Republic of the Congo, Sierra Leone, South Africa, Tanzania, Uganda, Zamibia, Zimbabwe
Timeline
2025
Target group
PLHIV and people without HIV
Vaccine
Hypothetical vaccine
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling, quantative
Partners involved
KNCV Tuberculosis Foundation, London School of Hygiene & Tropical Medicine, The Aurum Institute, University of the Witwatersrand, Vanderbilt University
Type of project
research
Funder
Civil Society
Governmental Body

Resources

New Tuberculosis vaccines for people with HIV

Contact

Tom Sumner
tom.sumner@lshtm.ac.uk
Click to copy link of this header Menu